Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Update on Vaccine-Derived Polioviruses - Worldwide, January 2017-June 2018.

Jorba J, Diop OM, Iber J, Henderson E, Zhao K, Sutter RW, Wassilak SGF, Burns CC.

MMWR Morb Mortal Wkly Rep. 2018 Oct 26;67(42):1189-1194. doi: 10.15585/mmwr.mm6742a5.

2.

Poliovirus excretion following vaccination with live poliovirus vaccine in patients with primary immunodeficiency disorders: clinicians' perspectives in the endgame plan for polio eradication.

Galal NM, Meshaal S, ElHawary R, Nasr E, Bassiouni L, Ashghar H, Farag NH, Mach O, Burns C, Iber J, Chen Q, ElMarsafy A.

BMC Res Notes. 2018 Oct 11;11(1):717. doi: 10.1186/s13104-018-3822-7.

3.

Strategic Response to an Outbreak of Circulating Vaccine-Derived Poliovirus Type 2 - Syria, 2017-2018.

Mbaeyi C, Wadood ZM, Moran T; MJourn, Ather F, Stehling-Ariza T, Nikulin J, Al Safadi M, Iber J, Zomahoun L, Abourshaid N, Pang H, Collins N, Asghar H, Butt OUI, Burns CC, Ehrhardt D, Sharaf M.

MMWR Morb Mortal Wkly Rep. 2018 Jun 22;67(24):690-694. doi: 10.15585/mmwr.mm6724a5.

4.

Vaccine-Derived Poliovirus Outbreaks and Events - Three Provinces, Democratic Republic of the Congo, 2017.

Alleman MM, Chitale R, Burns CC, Iber J, Dybdahl-Sissoko N, Chen Q, Van Koko DR, Ewetola R, Riziki Y, Kavunga-Membo H, Dah C, Andriamihantanirina R.

MMWR Morb Mortal Wkly Rep. 2018 Mar 16;67(10):300-305. doi: 10.15585/mmwr.mm6710a4.

5.

Dynamics of Evolution of Poliovirus Neutralizing Antigenic Sites and Other Capsid Functional Domains during a Large and Prolonged Outbreak.

Shaw J, Jorba J, Zhao K, Iber J, Chen Q, Adu F, Adeniji A, Bukbuk D, Baba M, Henderson E, Dybdahl-Sissoko N, McDonald S, Weldon WC, Gumede N, Oberste MS, Kew OM, Burns CC.

J Virol. 2018 Apr 13;92(9). pii: e01949-17. doi: 10.1128/JVI.01949-17. Print 2018 May 1.

6.

Are Circulating Type 2 Vaccine-derived Polioviruses (VDPVs) Genetically Distinguishable from Immunodeficiency-associated VDPVs?

Zhao K, Jorba J, Shaw J, Iber J, Chen Q, Bullard K, Kew OM, Burns CC.

Comput Struct Biotechnol J. 2017 Oct 12;15:456-462. doi: 10.1016/j.csbj.2017.09.004. eCollection 2017.

7.

Update on Vaccine-Derived Polioviruses - Worldwide, January 2016-June 2017.

Jorba J, Diop OM, Iber J, Henderson E, Sutter RW, Wassilak SGF, Burns CC.

MMWR Morb Mortal Wkly Rep. 2017 Nov 3;66(43):1185-1191. doi: 10.15585/mmwr.mm6643a6.

8.

The role of supplementary environmental surveillance to complement acute flaccid paralysis surveillance for wild poliovirus in Pakistan - 2011-2013.

Cowger TL, Burns CC, Sharif S, Gary HE Jr, Iber J, Henderson E, Malik F, Zahoor Zaidi SS, Shaukat S, Rehman L, Pallansch MA, Orenstein WA.

PLoS One. 2017 Jul 25;12(7):e0180608. doi: 10.1371/journal.pone.0180608. eCollection 2017.

9.

High-Throughput Next-Generation Sequencing of Polioviruses.

Montmayeur AM, Ng TF, Schmidt A, Zhao K, MagaƱa L, Iber J, Castro CJ, Chen Q, Henderson E, Ramos E, Shaw J, Tatusov RL, Dybdahl-Sissoko N, Endegue-Zanga MC, Adeniji JA, Oberste MS, Burns CC.

J Clin Microbiol. 2017 Feb;55(2):606-615. doi: 10.1128/JCM.02121-16. Epub 2016 Dec 7.

10.

Update on Vaccine-Derived Polioviruses - Worldwide, January 2015-May 2016.

Jorba J, Diop OM, Iber J, Sutter RW, Wassilak SG, Burns CC.

MMWR Morb Mortal Wkly Rep. 2016 Aug 5;65(30):763-9. doi: 10.15585/mmwr.mm6530a3.

11.

Environmental Isolation of Circulating Vaccine-Derived Poliovirus After Interruption of Wild Poliovirus Transmission - Nigeria, 2016.

Etsano A, Damisa E, Shuaib F, Nganda GW, Enemaku O, Usman S, Adeniji A, Jorba J, Iber J, Ohuabunwo C, Nnadi C, Wiesen E.

MMWR Morb Mortal Wkly Rep. 2016 Aug 5;65(30):770-3. doi: 10.15585/mmwr.mm6530a4.

12.

Importation and outbreak of wild polioviruses from 2000 to 2014 and interruption of transmission in Cameroon.

Endegue-Zanga MC, Sadeuh-Mba SA, Iber J, Burns CC, Moeletsi NG, Baba M, Bukbuk D, Delpeyroux F, Mengouo MN, Demanou M, Vernet G, Etoa FX, Njouom R.

J Clin Virol. 2016 Jun;79:18-24. doi: 10.1016/j.jcv.2016.03.025. Epub 2016 Mar 28.

PMID:
27045455
13.

Molecular Properties of Poliovirus Isolates: Nucleotide Sequence Analysis, Typing by PCR and Real-Time RT-PCR.

Burns CC, Kilpatrick DR, Iber JC, Chen Q, Kew OM.

Methods Mol Biol. 2016;1387:177-212. doi: 10.1007/978-1-4939-3292-4_9.

PMID:
26983735
14.

Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.

Famulare M, Chang S, Iber J, Zhao K, Adeniji JA, Bukbuk D, Baba M, Behrend M, Burns CC, Oberste MS.

J Virol. 2015 Oct 14;90(1):317-31. doi: 10.1128/JVI.01532-15. Print 2016 Jan 1.

15.

Field study of fecal excretion as a decision support tool in response to silent reintroduction of wild-type poliovirus 1 into Israel.

Moran-Gilad J, Mendelson E, Burns CC, Bassal R, Gdalevich M, Sofer D, Oberste MS, Shulman LM, Kaliner E, Hindiyeh M, Mor O, Shahar L, Iber J, Yishay R, Manor J, Lev B, Gamzu R, Grotto I.

J Clin Virol. 2015 May;66:51-5. doi: 10.1016/j.jcv.2015.03.005. Epub 2015 Mar 10. Erratum in: J Clin Virol. 2015 Aug;251. Hindiye, Musa [corrected to Hindiyeh, Musa].

PMID:
25866337
16.

Circulating vaccine-derived polioviruses in the Extreme North region of Cameroon.

Endegue-Zanga MC, Sadeuh-Mba SA, Iber J, Burns C, Nimpa-Mengouo M, Demanou M, Vernet G, Etoa FX, Njouom R.

J Clin Virol. 2015 Jan;62:80-3. doi: 10.1016/j.jcv.2014.11.027. Epub 2014 Nov 29.

PMID:
25542478
17.

Identification of vaccine-derived polioviruses using dual-stage real-time RT-PCR.

Kilpatrick DR, Ching K, Iber J, Chen Q, Yang SJ, De L, Williams AJ, Mandelbaum M, Sun H, Oberste MS, Kew OM.

J Virol Methods. 2014 Mar;197:25-8. doi: 10.1016/j.jviromet.2013.11.017. Epub 2013 Dec 7.

PMID:
24321704
18.

Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria.

Burns CC, Shaw J, Jorba J, Bukbuk D, Adu F, Gumede N, Pate MA, Abanida EA, Gasasira A, Iber J, Chen Q, Vincent A, Chenoweth P, Henderson E, Wannemuehler K, Naeem A, Umami RN, Nishimura Y, Shimizu H, Baba M, Adeniji A, Williams AJ, Kilpatrick DR, Oberste MS, Wassilak SG, Tomori O, Pallansch MA, Kew O.

J Virol. 2013 May;87(9):4907-22. doi: 10.1128/JVI.02954-12. Epub 2013 Feb 13.

19.

Poliovirus serotype-specific VP1 sequencing primers.

Kilpatrick DR, Iber JC, Chen Q, Ching K, Yang SJ, De L, Mandelbaum MD, Emery B, Campagnoli R, Burns CC, Kew O.

J Virol Methods. 2011 Jun;174(1-2):128-30. doi: 10.1016/j.jviromet.2011.03.020. Epub 2011 Apr 2.

PMID:
21440569
20.

Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population.

Wassilak S, Pate MA, Wannemuehler K, Jenks J, Burns C, Chenoweth P, Abanida EA, Adu F, Baba M, Gasasira A, Iber J, Mkanda P, Williams AJ, Shaw J, Pallansch M, Kew O.

J Infect Dis. 2011 Apr 1;203(7):898-909. doi: 10.1093/infdis/jiq140.

21.

Outbreak of poliomyelitis in Finland in 1984-85 - Re-analysis of viral sequences using the current standard approach.

Simonen ML, Roivainen M, Iber J, Burns C, Hovi T.

Virus Res. 2010 Jan;147(1):91-7. doi: 10.1016/j.virusres.2009.10.012. Epub 2009 Oct 31.

PMID:
19883702
22.

Rapid group-, serotype-, and vaccine strain-specific identification of poliovirus isolates by real-time reverse transcription-PCR using degenerate primers and probes containing deoxyinosine residues.

Kilpatrick DR, Yang CF, Ching K, Vincent A, Iber J, Campagnoli R, Mandelbaum M, De L, Yang SJ, Nix A, Kew OM.

J Clin Microbiol. 2009 Jun;47(6):1939-41. doi: 10.1128/JCM.00702-09. Epub 2009 Apr 22.

23.

Co-circulation and evolution of polioviruses and species C enteroviruses in a district of Madagascar.

Rakoto-Andrianarivelo M, Guillot S, Iber J, Balanant J, Blondel B, Riquet F, Martin J, Kew O, Randriamanalina B, Razafinimpiasa L, Rousset D, Delpeyroux F.

PLoS Pathog. 2007 Dec;3(12):e191.

24.

Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child.

Adu F, Iber J, Bukbuk D, Gumede N, Yang SJ, Jorba J, Campagnoli R, Sule WF, Yang CF, Burns C, Pallansch M, Harry T, Kew O.

Virus Res. 2007 Jul;127(1):17-25. Epub 2007 Apr 20.

PMID:
17449127
25.

Multiplex PCR method for identifying recombinant vaccine-related polioviruses.

Kilpatrick DR, Ching K, Iber J, Campagnoli R, Freeman CJ, Mishrik N, Liu HM, Pallansch MA, Kew OM.

J Clin Microbiol. 2004 Sep;42(9):4313-5.

26.

A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence.

Chou HH, Takematsu H, Diaz S, Iber J, Nickerson E, Wright KL, Muchmore EA, Nelson DL, Warren ST, Varki A.

Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11751-6.

27.

The effect of FMR1 CGG repeat interruptions on mutation frequency as measured by sperm typing.

Kunst CB, Leeflang EP, Iber JC, Arnheim N, Warren ST.

J Med Genet. 1997 Aug;34(8):627-31.

28.

Emerin deletion reveals a common X-chromosome inversion mediated by inverted repeats.

Small K, Iber J, Warren ST.

Nat Genet. 1997 May;16(1):96-9.

PMID:
9140403
29.

Characterization of the full fragile X syndrome mutation in fetal gametes.

Malter HE, Iber JC, Willemsen R, de Graaff E, Tarleton JC, Leisti J, Warren ST, Oostra BA.

Nat Genet. 1997 Feb;15(2):165-9.

PMID:
9020841

Supplemental Content

Support Center